Optimizing drug development: strategies to assess drug metabolism/transporter interaction potential—towards a consensus

Authors

  • Geoffrey T. Tucker,

    1. Molecular Pharmacology & Pharmacogenetics, Division of Clinical Sciences, University of Sheffield, The Royal Hallamshire Hospital, Sheffield S10 2JF,
    Search for more papers by this author
  • J. Brian Houston,

    1. School of Pharmacy & Pharmaceutical Sciences, University of Manchester, Manchester M13 9 PL, UK,
    Search for more papers by this author
  • Shiew-Mei Huang

    1. Office of Clinical Pharmacology & Biopharmaceutics (OCPB), Center for Drug Evaluation and Research, Food and Drug Administration, Rockville, MD 20852, USA
    Search for more papers by this author

Professor G. T. Tucker, Molecular Pharmacology & Pharmacogenetics, University of Sheffield, Floor L, The Royal Hallamshire Hospital, Sheffield S10 2JF UK. E-mail: G.T.Tucker@sheffield.ac.ukThis report is published simultaneously in Eur J Pharm Sci, Clin Pharmacol Ther, J Clin Pharmacol and Pharm Res.

Ancillary